Sponsor & Developer Portfolio
Mercy Medical Center
Clinical development pipeline, platform architecture, and registered trial tracking for Mercy Medical Center vaccine candidates.
1
Candidates
1
Target Diseases
1
Linked Studies
Development Phase Distribution
Phase 3 Clinical Trial: 1
Platform Technologies
Biological (unspecified platform): 1
Target Pathogens & Indications
Hepatitis B
Vaccine Pipeline Candidates (1)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Phase 3 Clinical Trial
ctgov-heplisav-b-injectable-product-2-dose-regimen-mercy-medical-cente
Heplisav-B Injectable Product, 2-dose regimen
Target: Hepatitis B
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2028-12-01 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.